Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Xenon Quells Rat Response To Traumatic Memories

Already an anesthetic, the gaseous element might be developed into a PTSD treatment for humans

by Carmen Drahl
September 1, 2014 | APPEARED IN VOLUME 92, ISSUE 35

Xenon At A Glance



Characteristics: Colorless, odorless noble gas with eight stable isotopes

Source: Extracted from air

Lights up: Used in lights, lasers, medical imaging agents

Lights out: Blocks glutamate receptors to produce anesthesia

Forbidden: Boosts erythropoietin and O2 capacity, banned by World Anti-Doping Agency

Pencil in one more possible use for the element xenon: In addition to being an anesthetic and medical imaging agent, the noble gas could become a treatment for posttraumatic stress disorder (PTSD). Among its biological effects, xenon blocks glutamate receptors involved in reconsolidation—a process in which a reactivated old memory gets packed away by the brain as if it were new. That got neuroscientist Edward G. Meloni of McLean Hospital, in Belmont, Mass., thinking that xenon might help PTSD patients, who reexperience painful memories when reminded of past traumas. Meloni teamed with Harvard Medical School researchers to test the hypothesis in rats. The team shocked the rats’ feet after playing a tone, conditioning the animals to freeze in fear upon hearing the tone days later. When the researchers played the tone and then immediately exposed rats to a puff of xenon—below the amount it would take to anesthetize them—the rats’ fear responses were reduced for up to two weeks (PLOS One 2014, DOI: 10.1371/journal.pone.0106189). Current PTSD treatments rarely fix underlying problems, so xenon may prove helpful if future research can demonstrate that the treatment won’t disrupt beneficial memories, says Christopher K. Cain, who studies PTSD at New York University.



This article has been sent to the following recipient:

Leave A Comment

*Required to comment